Patents by Inventor Timothy R. Compton

Timothy R. Compton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090099240
    Abstract: Disclosed herein are methods for treating energy metabolism disorders by administering a composition containing a therapeutically effective amount of a fatty acid amide hydrolase inhibitor. The composition can also be administered to reduce body fat, body weight, or caloric intake.
    Type: Application
    Filed: October 2, 2007
    Publication date: April 16, 2009
    Applicant: N.V. Organon
    Inventors: Jeff A. Parrott, Timothy R. Compton, Olivier Dasse, David Putman
  • Publication number: 20080119549
    Abstract: Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH activity. Compounds disclosed herein inhibit FAAH activity. Described herein are processes for the preparation of esters of alkylcarbamic acid compounds, compositions that include them, and methods of use thereof.
    Type: Application
    Filed: July 5, 2007
    Publication date: May 22, 2008
    Applicant: N.V. Organon
    Inventors: Olivier DASSE, David Putman, Timothy R. Compton, Jeff A. Parrott
  • Publication number: 20070155707
    Abstract: Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH activity. Compounds disclosed herein inhibit FAAH activity. Described herein are processes for the preparation of esters of alkylcarbamic acid compounds, compositions that include them, and methods of use thereof.
    Type: Application
    Filed: November 20, 2006
    Publication date: July 5, 2007
    Applicant: Kadmus Pharmaceuticals, Inc.
    Inventors: Olivier Dasse, David Putman, Timothy R. Compton
  • Patent number: 6500633
    Abstract: The present invention relates to methods of detecting carcinomas by measuring the level of a glycero compound, such as glycerol-3-phosphate, in a plasma, serum, or urine specimen from a patient. The method is particularly useful as a screening test for ovarian and breast carcinomas.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: December 31, 2002
    Assignee: Atairgin Technologies, Inc.
    Inventors: Timothy R. Compton, Jeff A. Parrott, James R. Erickson, Robert L. Wolfert